argenx SE (NASDAQ:NASDAQ:ARGX) Q1 2022 Earnings Conference Call May 5, 2022 8:30 ET Corporate Participants Beth DelGiacco - VP Corporate Communications and Investor Relations Tim Van.
Neurocrine Biosciences, Inc. (NASDAQ:NASDAQ:NBIX) Q1 2022 Earnings Conference Call May 04, 2022, 08:00 ET Company Participants Todd Tushla - VP, IR Kevin Gorman - CEO & Director Matthew.